Cargando…

Stem Cells in Heart Failure

Detalles Bibliográficos
Autores principales:	Kania, Gabriela, Boheler, Kenneth R., Landmesser, Ulf, Wojakowski, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236426/ https://www.ncbi.nlm.nih.gov/pubmed/22190962 http://dx.doi.org/10.4061/2011/193918

Ejemplares similares

Multipotent to Pluripotent Properties of Adult Stem Cells
por: Bhartiya, Deepa, et al.
Publicado: (2013)

Editorial: Cutting Edge Methodologies in Experimental Cardiovascular Research
por: Błyszczuk, Przemysław, et al.
Publicado: (2020)

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives
por: Chow, Maggie Zi, et al.
Publicado: (2013)

Functional Properties of Engineered Heart Slices Incorporating Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Blazeski, Adriana, et al.
Publicado: (2019)

Concise Review: Cell Surface N‐Linked Glycoproteins as Potential Stem Cell Markers and Drug Targets
por: Boheler, Kenneth R., et al.
Publicado: (2016)

Time-related factors predicting a positive response to cardiac resynchronisation therapy in patients with heart failure
por: Wilczek, Jacek, et al.
Publicado: (2023)

Induced pluripotent stem cell-derived vascular smooth muscle cells
por: Stephenson, Makeda, et al.
Publicado: (2019)

Thrombus aspiration in STEMI revisited: impact on coronary microcirculation?
por: Fröhlich, Georg M, et al.
Publicado: (2015)

Challenging clinical and organizational scenarios in cardiovascular diseases during the SARS-CoV-2 pandemic in Poland. Can we do better?
por: Wojakowski, Wojciech, et al.
Publicado: (2020)

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
por: Bartunek, Jozef, et al.
Publicado: (2020)

The Year in Cardiology 2015: Prevention
por: Chapman, M. John, et al.
Publicado: (2016)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Heart Failure
por: Giamouzis, Gregory, et al.
Publicado: (2011)

Heart Failure
por: Wang, Yanggan, et al.
Publicado: (2014)

FD-OCT and IVUS for detection of incomplete stent apposition in heavily calcified vessels: novel insights
por: Leistner, David M, et al.
Publicado: (2015)

Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes
por: Keung, Wendy, et al.
Publicado: (2014)

Nanotechnology and stem cells in vascular biology
por: Jadczyk, Tomasz, et al.
Publicado: (2019)

Maturing heart muscle cells: Mechanisms and transcriptomic insights
por: Murphy, Sean A., et al.
Publicado: (2021)

Acute heart failure facts and numbers: acute heart failure populations
por: Searle, Julia, et al.
Publicado: (2016)

Heart Failure 2013
por: Giamouzis, Gregory, et al.
Publicado: (2013)

Heart Failure 2012
por: Giamouzis, Gregory, et al.
Publicado: (2012)

Heart failure in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2016)

Sudden Heart Failure
Publicado: (1950)

Stroke in Heart Failure
por: Essa, Hani, et al.
Publicado: (2020)

Why “Heart-Failure?”
Publicado: (1892)

International Journal of Heart Failure: a Premier Journal for Research in Heart Failure
por: Choi, Dong-Ju
Publicado: (2019)

Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure
por: Madonna, Rosalinda
Publicado: (2022)

Enhanced Proliferation of Monolayer Cultures of Embryonic Stem (ES) Cell-Derived Cardiomyocytes Following Acute Loss of Retinoblastoma
por: Yamanaka, Satoshi, et al.
Publicado: (2008)

Surgical treatment concepts for heart failure
por: Delmo Walter, E M, et al.
Publicado: (2013)

Severe heart failure in the setting of inflammatory cardiomyopathy with likely pathogenic titin variant
por: Mueller, Melina, et al.
Publicado: (2022)

Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models
por: Chua, Christianne J., et al.
Publicado: (2023)

Novel Therapies for Heart Failure
Publicado: (2015)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Right heart failure syndrome
por: Soliman, Osama, et al.
Publicado: (2018)

Targeting breathlessness in heart failure
por: Coats, Andrew J. Stewart
Publicado: (2020)

Heart Failure Research and Polypharmacy
por: Somberg, John
Publicado: (2022)

Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure
por: Epstein, Stephen E., et al.
Publicado: (2018)

The treatment of heart failure: an ideal challenge for the heart team
por: Reichenspurner, Hermann
Publicado: (2019)

From mechanisms of heart failure to clinical heart success
por: Bakkers, Jeroen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b03g4e4cfudfv7gp6edtc67d1k